top of page
Abstract Crystal Burst

Simplifying Chronic Care

Anodyne is a clinical-stage biotech company simplifying chronic care for every stakeholder. ​We enable the transdermal delivery of

multi-milligram doses and complex formulations of existing therapies and emerging large molecules.

AnodyneNanotech_Patch

The HeroPatch

By transdermally delivering multi-milligram doses of large molecules, we enable:

​

  • Tunable Pharmacokinetic profiles

  • New formulation by utilizing the APIs' dry form 

  • Room temperature stability

  • Combination therapies of next-gen therapeutics

Our Pipeline

We are advancing a pipeline of transdermal biologic and peptide therapies targeting high-value indications in metabolic disease, endocrinology, and age-related conditions such as obesity and sarcopenia.

Test Tubes
Team meeting

Partnerships & Collaborations

Anodyne is actively expanding its pipeline through both internal clinical development and strategic external partnerships to maximize the commercial potential and clinical impact of its cutting-edge drug delivery platform.

bottom of page